Home > Boards > US OTC > Medical - Healthcare > InVivo Therapeutics Holdings Corp (NVIV)

OK - they have the science...

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
XenaLives Member Profile
Member Level 
Followed By 335
Posts 44,740
Boards Moderated 26
Alias Born 09/20/01
160x600 placeholder
InVivo Therapeutics Announces Closing of $15.0 Million Public Offering Business Wire - 10/26/2020 4:15:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/26/2020 6:03:09 AM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) Edgar (US Regulatory) - 10/26/2020 6:02:10 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 10/23/2020 4:39:28 PM
InVivo Therapeutics Announces Pricing of $15.0 Million Public Offering Business Wire - 10/22/2020 9:15:00 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 10/7/2020 6:01:32 AM
InVivo Therapeutics Announces Presentation at the Upcoming H.C Wainwright Virtual Global Investment Conference Business Wire - 9/11/2020 8:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/11/2020 4:15:47 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2020 4:34:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/23/2020 6:37:34 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 6/22/2020 6:04:21 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 6/9/2020 4:31:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/5/2020 4:06:18 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 6/5/2020 6:01:40 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 6/4/2020 4:35:19 PM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 5/22/2020 5:26:10 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/13/2020 4:07:21 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 4/28/2020 4:15:49 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 4/24/2020 5:05:10 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 4/24/2020 4:15:10 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 4/24/2020 11:19:24 AM
InVivo Therapeutics Announces Closing of $3.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules Business Wire - 4/17/2020 12:19:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 4/17/2020 6:01:44 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/16/2020 5:20:33 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 4/16/2020 11:30:13 AM
XenaLives Member Level  Friday, 01/17/20 07:06:32 AM
Re: None
Post # of 6165 
OK - they have the science...

From the intro:
Quote:
About InVivo Therapeutics

InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 with proprietary technology co-invented by Robert Langer, Sc.D., Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who then was at Boston Children’s Hospital and who now is affiliated with Massachusetts General Hospital. In 2011, the company earned the David S. Apple Award from the American Spinal Injury Association for its outstanding contribution to spinal cord injury medicine. In 2015, the company’s investigational Neuro-Spinal Scaffold received the 2015 Becker’s Healthcare Spine Device Award. The publicly-traded company is headquartered in Cambridge, MA. For more details, visit http://www.invivotherapeutics.com.


Management: http://www.invivotherapeutics.com/about-us/our-team/
Ongoing Human Trials: https://clinicaltrials.gov/ct2/results?term=%22invivo+therapeutics%22&Search=Search
SEC Filings: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001292519&owner=exclude&count=40&hidefilings=0
Recent News: http://finance.yahoo.com/q/h?s=NVIV+Headlines
Share Structure: http://www.otcmarkets.com/stock/NVIV/profile




Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences